{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:54:37Z","timestamp":1791842077481,"version":"4.3.4"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.00501","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T01:18:56Z","timestamp":1593134336000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":381,"title":["Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide"],"prefix":"10.3389","volume":"11","author":[{"given":"Jyh Yung","family":"Hor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Broadley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Isabel","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najib","family":"Kissani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Marignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Weinshenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Pittock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Palace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean M.","family":"Wingerchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinta M.","family":"Behne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Yeaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Fujihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1759-1961.2012.00030.x","article-title":"Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease","volume":"3","author":"Fujihara","year":"2012","journal-title":"Clin Exp Neuroimmunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/WCO.0000000000000694","article-title":"Neuromyelitis optica spectrum disorders: still evolving and broadening","volume":"32","author":"Fujihara","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00281-018-0723-8","article-title":"Sex differences in autoimmune disorders of the central nervous system","volume":"41","author":"Gold","year":"2019","journal-title":"Semin Immunopathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/jnnp-2016-313300","article-title":"Neurodegeneration in multiple sclerosis and neuromyelitis optica","volume":"88","author":"Kawachi","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/cen3.12262","article-title":"Anti-myelin oligodendrocyte glycoprotein antibody in demyelinating diseases","volume":"6","author":"Nakashima","year":"2015","journal-title":"Clin Exp Neuroimmunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1212\/NXI.0000000000000322","article-title":"MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy","volume":"4","author":"Ogawa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/cen3.12434","article-title":"Myelin oligodendrocyte glycoprotein immunoglobulin G-associated disease: an overview","volume":"9","author":"Fujihara","year":"2018","journal-title":"Clin Exp Neuroimmunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e543","DOI":"10.1212\/NXI.0000000000000543","article-title":"Cranial nerve involvement in patients with MOG antibody-associated disease","volume":"6","author":"Cobo-Calvo","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B15","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"B16","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1136\/jnnp-2015-312601","article-title":"Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica","volume":"87","author":"Waters","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e674","DOI":"10.1212\/NXI.0000000000000674","article-title":"International multicenter examination of MOG antibody assays","volume":"7","author":"Reindl","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000342779","article-title":"Incidence and prevalence of multiple sclerosis in the Americas: a systematic review","volume":"40","author":"Evans","year":"2013","journal-title":"Neuroepidemiology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2377-13-128","article-title":"Incidence and prevalence of multiple sclerosis in europe: a systematic review","volume":"13","author":"Kingwell","year":"2013","journal-title":"BMC Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1212\/wnl.56.4.507","article-title":"MS and neuromyelitis optica in Martinique (French West Indies)","volume":"56","author":"Cabre","year":"2001","journal-title":"Neurology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.neurol.2009.02.012","article-title":"Descriptive epidemiology of neuromyelitis optica in the caribbean basin [article in french, with english abstract]","volume":"165","author":"Cabre","year":"2009","journal-title":"Rev Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00415-009-0009-0","article-title":"An epidemiological study on neuromyelitis optica in Cuba","volume":"256","author":"Cabrera-G\u00f3mez","year":"2009","journal-title":"J Neurol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","article-title":"A population-based study of neuromyelitis optica in Caucasians","volume":"76","author":"Asgari","year":"2011","journal-title":"Neurology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jns.2012.08.032","article-title":"Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan","volume":"323","author":"Houzen","year":"2012","journal-title":"J Neurol Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e01338","DOI":"10.1002\/brb3.1338","article-title":"Epidemiology of neuromyelitis optica spectrum disorder in Denmark (1998\u20132008, 2007\u20132014)","volume":"9","author":"Asgari","year":"2019","journal-title":"Brain Behav"},{"key":"B28","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1468-1331.2011.03529.x","article-title":"The prevalence of neuromyelitis optica in south east wales","volume":"19","author":"Cossburn","year":"2012","journal-title":"Eur J Neurol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1007\/s00415-013-6926-y","article-title":"The epidemiology of neuromyelitis optica amongst adults in the merseyside county of United Kingdom","volume":"260","author":"Jacob","year":"2013","journal-title":"J Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e79649","DOI":"10.1371\/journal.pone.0079649","article-title":"Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8","volume":"8","author":"Aboul-Enein","year":"2013","journal-title":". PLoS ONE"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1177\/1352458514521503","article-title":"Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India","volume":"20","author":"Pandit","year":"2014","journal-title":"Mult Scler"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1177\/1352458514537699","article-title":"An epidemiological study of neuromyelitis optica in Isfahan","volume":"20","author":"Etemadifar","year":"2014","journal-title":"Mult Scler"},{"key":"B33","first-page":"204","article-title":"A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in khuzestan province, Iran","volume":"14","author":"Kashipazha","year":"2015","journal-title":"Iran J Neurol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2055217315625652","DOI":"10.1177\/2055217315625652","article-title":"Incidence of AQP4-IgG seropositive neuromyelitis optica spectrum disorders in the Netherlands: about one in a million","volume":"2","author":"van Pelt","year":"2016","journal-title":"Mult Scler Exp Transl Clin"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1212\/WNL.0000000000004611","article-title":"Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan","volume":"89","author":"Houzen","year":"2017","journal-title":"Neurology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.msard.2017.10.007","article-title":"Neuromyelitis optica spectrum disorders in Iran","volume":"18","author":"Eskandarieh","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1177\/1352458517735191","article-title":"Epidemiology of NMOSD in catalonia: influence of the new 2015 criteria in incidence and prevalence estimates","volume":"24","author":"Sep\u00falveda","year":"2018","journal-title":"Mult Scler"},{"key":"B39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.msard.2017.10.015","article-title":"Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic penang island, malaysia, and a review of worldwide prevalence","volume":"19","author":"Hor","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"B40","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/jnnp-2017-317321","article-title":"Nationwide epidemiological study of neuromyelitis optica in Japan","volume":"89","author":"Miyamoto","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/cen3.12458","article-title":"Prevalence and characteristics of transverse myelitis and neuromyelitis optica spectrum disorders in the United Arab Emirates: a multicenter, retrospective study","volume":"9","author":"Holroyd","year":"2018","journal-title":"Clin Exp Neuroimmunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e2265","DOI":"10.1212\/WNL.0000000000006645","article-title":"Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark","volume":"91","author":"Papp","year":"2018","journal-title":"Neurology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1212\/WNL.0000000000007746","article-title":"Epidemiology of NMOSD in Sweden from 1987 to 2013: a nationwide population-based study","volume":"93","author":"Jonsson","year":"2019","journal-title":"Neurology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519888609.","article-title":"Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea","author":"Kim","year":"2019","journal-title":"Mult Scler"},{"key":"B45","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/ene.14079","article-title":"A population-based epidemiological study of neuromyelitis optica spectrum disorder in hungary","volume":"27","author":"Papp","year":"2020","journal-title":"Eur J Neurol"},{"key":"B46","article-title":"NMOSD and MS prevalence in the indigenous populations of Australia and New Zealand","volume-title":"Presented at the 12th Congress of the Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS)","author":"Bukhari","year":"2019"},{"key":"B47","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/jnnp-2016-314839","article-title":"Incidence and prevalence of NMOSD in Australia and New Zealand","volume":"88","author":"Bukhari","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.3346\/jkms.2020.35.e115","article-title":"Prevalence and incidence of neuromyelitis optica spectrum disorder in Korea: population based study","volume":"35","author":"Lee","year":"2020","journal-title":"J Korean Med Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1399-0039.2008.01172.x","article-title":"Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders","volume":"73","author":"Matsushita","year":"2009","journal-title":"Tissue Antigens"},{"key":"B50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jneuroim.2010.11.004","article-title":"HLA-DPB1*0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in Southern Han Chinese","volume":"233","author":"Wang","year":"2011","journal-title":"J Neuroimmunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/jnnp-2012-302925","article-title":"Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin-4 antibody status","volume":"84","author":"Yoshimura","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B52","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0022-510X(71)90110-9","article-title":"The pattern of neurological illness in tropical Africa: experience at Ibadan, Nigeria","volume":"12","author":"Osuntokun","year":"1971","journal-title":"J Neurol Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1126\/science.1243518","article-title":"A genetic atlas of human admixture history","volume":"343","author":"Hellenthal","year":"2014","journal-title":"Science"},{"key":"B54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0022-510X(87)90154-7","article-title":"The epidemiology of multiple sclerosis in Queensland, Australia","volume":"80","author":"Hammond","year":"1987","journal-title":"J Neurol Sci"},{"key":"B55","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5694\/j.1326-5377.1994.tb126553.x","article-title":"Epidemiology of multiple sclerosis in Australia: with NSW and SA survey results","volume":"160","author":"McLeod","year":"1994","journal-title":"Med J Aust"},{"key":"B56","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1212\/WNL.56.3.317","article-title":"Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica","volume":"56","author":"Mirsattari","year":"2001","journal-title":"Neurology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s00415-008-0781-2","article-title":"Characteristics of devic's disease (neuromyelitis optica) in Mexico","volume":"255","author":"Rivera","year":"2008","journal-title":"J Neurol"},{"key":"B58","article-title":"Neuromyelitis optica spectrum disorders: epidemiologic study in Venezuela","volume-title":"Presented at the 11th International NMO Roundtable Conference","author":"Soto de Castillo","year":"2019"},{"key":"B59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.msard.2015.12.005","article-title":"Neuromyelitis optica spectrum disorders in algeria: a preliminary study in the region of tizi ouzou","volume":"6","author":"Daoudi","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"B60","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jneuroim.2018.08.014","article-title":"Clinical and radiological characteristics of neuromyelitis optica spectrum disorder in the North Egyptian Nile Delta","volume":"324","author":"Salama","year":"2018","journal-title":"J Neuroimmunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.msard.2019.06.002","article-title":"Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008 - 2018: a nationwide, population-based cohort study","volume":"33","author":"Boesen","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"B62","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00415-019-09647-9","article-title":"Epidemiology of pediatric multiple sclerosis, neuromyelitis optica, and optic neuritis in Taiwan","volume":"267","author":"Lin","year":"2019","journal-title":"J Neurol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1093\/brain\/aws109","article-title":"Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan","volume":"135","author":"Kitley","year":"2012","journal-title":"Brain"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/brain\/awz054","article-title":"Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrums disorders","volume":"142","author":"Palace","year":"2019","journal-title":"Brain"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e2089","DOI":"10.1212\/WNL.0000000000006574","article-title":"Racial differences in neuromyelitis optica spectrum disorder","volume":"91","author":"Kim","year":"2018","journal-title":"Neurology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e468","DOI":"10.1212\/NXI.0000000000000468","article-title":"Mortality in neuromyelitis optica is strongly associated with African ancestry","volume":"5","author":"Mealy","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1177\/1352458515614093","article-title":"The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients","volume":"22","author":"Siritho","year":"2016","journal-title":"Mult Scler"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1007\/s00415-017-8596-7","article-title":"What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive?","volume":"264","author":"Hamid","year":"2017","journal-title":"J Neurol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.msard.2018.07.026","article-title":"Lower frequency of antibodies to MOG in Brazilian patients with demyelinating diseases: an ethnicity influence?","volume":"25","author":"Papais-Alvarenga","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"B71","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/cen3.12491","article-title":"Neuromyelitis optica spectrum and myelin oligodendrocyte glycoprotein antibody-related disseminated encephalomyelitis","volume":"10","author":"Misu","year":"2019","journal-title":"Clin Exp Neuroimmunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1212\/NXI.0000000000000062","article-title":"Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?","volume":"2","author":"Zamvil","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B73","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.msard.2018.07.025","article-title":"MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder","volume":"25","author":"Narayan","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519845112.","article-title":"The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults","author":"de Mol","year":"2019","journal-title":"Mult Scler"},{"key":"B75","volume-title":"Diagnostic and Advisory Service for Neuromyelitis Optica (NMO) Annual Report 2018","year":"2018"},{"key":"B76","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/jamaneurol.2019.3656","article-title":"Coexistence of myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies in adult and pediatric patients","volume":"77","author":"Kunchok","year":"2020","journal-title":"JAMA Neurol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1136\/jnnp-2018-320243","article-title":"Seroprevalence and clinical phenotype of MOG-IgG-associated disorders in Sri Lanka","volume":"90","author":"Senanayake","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B78","first-page":"160","article-title":"The epidemiology of myelin oligodendrocyte glycoprotein antibody associated disorders","volume":"25","author":"Flanagan","year":"2019","journal-title":"Mult Scler"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00501\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T01:19:02Z","timestamp":1593134342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00501\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":78,"alternative-id":["10.3389\/fneur.2020.00501"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.00501","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"article-number":"501"}}